Proceedings in Obstetrics and Gynecology
Not a member yet
462 research outputs found
Sort by
Anti-Müllerian Hormone concentration levels in maternal plasma during the first, second and third trimester of pregnancy
Follicle-Stimulating Hormone (FSH) drops rapidly in pregnancy but Anti-Mullerian Hormone (AMH) has not been shown to drop until about 12 weeks. Since the follicles that secrete AMH are thought to be FSH independent, AMH levels should slowly decline in the absence of FSH because when the follicles reach FSH dependence, they would die off. A study has presented data that suggests a decline in AMH levels suddenly starts at 12 weeks gestation. The present study agrees with a decline in AMH after the first trimester. There is a sharp decline in AMH at 12-16 weeks gestation indicating that the follicular development is actively suppressed, not passively lost because of a drop in FSH. It appears that pregnancy may be a unique situation in regards to AMH
Women’s Health educational opportunities at the University of Iowa’s Department of Obstetrics and Gynecology
The Department of Obstetrics and Gynecology’s educational programs span a continuum of learners from undergraduate premedical students to continuing education for practicing providers in Iowa and nearby states. The Department of Obstetrics and Gynecology is committed to teaching women-centered, compassionate, evidence-based care and fostering life-long learning. The Department of Obstetrics and Gynecology is a part of the Roy J. and Lucille A. Carver College of Medicine and the University of Iowa Health Care at the University of Iowa
Division of Gynecologic Oncology
The Gynecologic Oncology Division at the University of Iowa consists of four attending physicians, three fellows-in-training, two physician assistants, three nurses and supporting research and clerical staff. The concentration of our division remains the care of women with gynecologic malignancies. Our service area includes all counties of Iowa as well as western Illinois. Our patients are seen and treated in the National Cancer Institute designated Holden Comprehensive Cancer Center on the University of Iowa Hospitals campus